ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

IMVT Immunovant Inc

28.95
0.56 (1.97%)
25 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Immunovant Inc IMVT NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.56 1.97% 28.95 10:00:00
Open Price Low Price High Price Close Price Previous Close
28.52 28.24 29.33 28.95 28.39
more quote information »

Recent News

Date Time Source Heading
25/5/202406:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/5/202406:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/5/202406:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/5/202406:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/3/202422:30GLOBEImmunovant Awarded U.S. Patent for IMVT-1402
24/2/202408:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/2/202408:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/2/202408:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202400:47EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
12/2/202423:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
12/2/202423:02EDGAR2Form 8-K - Current report
30/1/202408:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/1/202408:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/1/202423:29EDGAR2Form 3 - Initial statement of beneficial ownership of..
13/1/202408:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/1/202408:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/1/202408:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/1/202400:08EDGAR2Form 8-K - Current report
04/1/202400:00GLOBEImmunovant to Present at the 42nd Annual J.P. Morgan..
21/12/202309:40DJNImmunovant Gets Positive Data From Graves' Disease Treatment..
21/12/202308:37EDGAR2Form 8-K - Current report
21/12/202308:30GLOBEImmunovant Reports Positive Initial Phase 2 Results for..
28/11/202323:43EDGAR2Form 8-K - Current report
28/11/202323:00GLOBERoivant Announces Positive IMVT-1402 Initial 600 mg MAD..
25/11/202306:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/11/202306:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/11/202306:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/11/202306:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/11/202300:00GLOBEImmunovant to Present at Upcoming Investor Conferences
10/11/202300:49EDGAR2Form S-3ASR - Automatic shelf registration statement of..
09/11/202323:13EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202323:06EDGAR2Form 8-K - Current report
09/11/202323:00GLOBEImmunovant Reports Financial Results and Provides Corporate..
21/10/202307:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/10/202307:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/10/202308:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/10/202308:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/10/202307:52GLOBEImmunovant Announces Closing of Upsized Common Stock..
30/9/202306:48EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
29/9/202307:23EDGAR2Form 8-K - Current report
28/9/202320:09EDGAR2Form FWP - Filing under Securities Act Rules 163/433 of free..
28/9/202313:41GLOBEImmunovant Announces Pricing of $450 Million Common Stock..
27/9/202307:28EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
27/9/202307:00GLOBEImmunovant Announces Proposed Offering of $300 Million of..
26/9/202321:45EDGAR2Form 8-K - Current report
26/9/202320:00GLOBEImmunovant Announces Positive Initial IMVT-1402 Phase 1 SAD..
26/9/202313:01GLOBEImmunovant to Host Conference Call and Webcast to Report..
02/9/202306:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/8/202307:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/8/202307:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Your Recent History

Delayed Upgrade Clock